Xenetic Biosciences, Inc. (XBIO)

Xenetic Biosciences Revenue

Xenetic Biosciences had revenue of $806.92K in the quarter ending March 31, 2026, with 36.01% growth. This brings the company's revenue in the last twelve months to $3.19M, up 23.52% year-over-year. In the year 2025, Xenetic Biosciences had annual revenue of $2.98M with 19.04% growth.

• Revenue (ttm): $3.19M
• Revenue Growth: +23.52%
• P/S Ratio: 2.14
• Revenue / Employee: $1,595,037
• Employees: 2
• Market Cap: 7.08M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.98M	476.13K	19.04%
Dec 31, 2024	2.50M	-39.71K	-1.56%
Dec 31, 2023	2.54M	833.06K	48.80%
Dec 31, 2022	1.71M	546.24K	47.06%
Dec 31, 2021	1.16M	723.75K	165.64%
Dec 31, 2020	436.94K	419.88K	2,460.31%
Dec 31, 2019	17.07K	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	7.59M	4.59M	152.83%
Dec 31, 2016	3.00M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	1.00M	706.40K	240.60%
Dec 31, 2012	293.60K	-	-
Aug 31, 2012	-	-	-

Data Source: Fiscal.ai Last updated: May 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 23, 2026

Data Sources Report a data error